High-risk Stage II Colorectal Cancers Carry an Equivalent Risk of Peritoneal Recurrence to Stage III

Background/Aim: Several risk factors for recurrence have been identified in stage II colorectal cancer. However, in contrast to stage III, the benefits of adjuvant chemotherapy for these patients remain controversial. We hypothesized that the different impacts of chemotherapy may be due to different...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:In Vivo
Główni autorzy: NOZAWA, HIROAKI, KAWAI, KAZUSHIGE, HATA, KEISUKE, TANAKA, TOSHIAKI, NISHIKAWA, TAKESHI, OTANI, KENSUKE, SASAKI, KAZUHITO, KANEKO, MANABU, EMOTO, SHIGENOBU, MURONO, KOJI
Format: Artigo
Język:Inglês
Wydane: International Institute of Anticancer Research 2018
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199616/
https://ncbi.nlm.nih.gov/pubmed/30150450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11370
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy